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Abstract
Dendritic cells (DCs) that orchestrate mucosal immunity have been studied in mice. Here we 
characterize human gut DC populations, and define their relationship to previously studied human 
and mouse DCs. CD103+Sirpα− DCs were related to human blood CD141+ and to mouse 
intestinal CD103+CD11b− DCs and expressed markers of cross-presenting DCs. CD103+Sirpα+ 
DCs aligned with human blood CD1c+ DCs and mouse intestinal CD103+CD11b+ DCs and 
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supported regulatory T cell induction. Both CD103+ DC subsets induced TH17 cells, while 
CD103−Sirpα+ DCs induced TH1 cells. Comparative transcriptomics revealed conserved 
transcriptional programs among CD103+ DC subsets and uncovered a selective role for Bcl-6 and 
Blimp-1 in CD103+Sirpα− and intestinal CD103+CD11b+ DC specification, respectively. These 
results highlight evolutionarily conserved and divergent programming of intestinal DCs.
The gastro-intestinal tract is challenged by a multitude of antigens, including commensal 
microflora, food antigens and invasive pathogens. Animal models have begun to define a 
critical role for dendritic cell (DC) specialization in achieving the balance between 
tolerogenic and inflammatory immune responses in the intestine. Diversity in intestinal DC 
phenotype and function has been extensively studied in mice using model systems based on 
conditional ablation of DCs and engraftment with defined DC precursors1,2. The mouse 
CD103+CD11b+ (mDP for mouse double positive) and CD103+CD11b− (mSP for mouse 
single positive) DCs require distinct genetic factors for their development and display 
unique gene expression profiles3. mSP DCs are closely related to cross-presenting CD8α+ 
DCs of splenic origin, and both require the transcription factors BATF3, Id2 and IRF8 for 
development4. mDP DCs are potent inducers of CD4+ T cell responses of both inflammatory 
and tolerizing nature5-8, and share a requirement for the transcription factors IRF49 and 
Notch210 with lymphoid resident CD4+CD8α− DC.
Recent studies have identified CD141 as a marker of human cross-presenting cDCs, the 
putative homologs of mouse CD8α+ DCs, in human blood, spleen, lymph nodes and 
skin11-13. In addition, CLEC9A+Sirpα−CD103+ DC have been identified in the human 
ileum9. However the phenotypic features and functional specialization of human intestinal 
DCs, as well as the transcriptional programs of various DC subsets, remain to be studied.
Our goal here was to identify discrete DC subsets in the human intestinal LP, to relate them 
to mouse intestinal DC populations by identifying evolutionarily conserved phenotypic 
features and to start characterizing their functional specialization. We also performed 
genome-wide expression analysis to define transcriptional fingerprints for each DC subset in 
the gut, and to correlate gene expression in human and mouse DC subsets from lymphoid 
and non-lymphoid sites. We identified CD103 (αE) and Sirpα (CD172a) as conserved 
markers that define three major subpopulations of conventional CD11c+ DCs in the human 
gut mucosa. Our analyses revealed that human CD103+Sirpα+ (hDP, for human double 
positive) DCs and mDP DCs have a common set of phenotypic characteristics (i.e. 
CLEC4A+, CD101+, TLR5+, CCR7hi, CD11b+ and Sirpα+). Human gut CD103+Sirpα− 
(hSP, for human single positive) DCs share significant transcriptomic similarities with 
human blood CD141+ and mSP DCs, including expression of CLEC9A, CADM1 and 
XCR113. We also identified a population of human CD103−Sirpα+ cDCs that had increased 
frequency in inflamed gut specimens, and expressed transcription factors and gene profiles 
consistent with monocyte-derived DCs.
Using comparative transcriptomics, we identified transcription factors whose expression was 
coordinately regulated in these human and mouse intestinal DC subsets. In addition to IRF8, 
a transcription factor previously implicated in intestinal DC development, our analyses 
revealed conserved expression of Bcl6 in hSP and mSP DCs, and of Irf4 and Prdm1 
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(encoding Blimp-1) in hDP and mDP DCs. Selective loss of intestinal mDP DCs was 
reported in mice with DC-specific IRF4-deficiency9,14. We show here that Bcl-6 and 
Blimp-1 control the specification of intestinal mSP and mDP DC subsets. Bcl-6 is required 
for the development of intestinal mSP, as well as for lymphoid tissue CD8α+ DCs, while 
Blimp-1 deficiency specifically affects the unique mDP subset in the intestine. Hence, in 
parallel to their counter-regulatory roles in effector T and B cell differentiation, Bcl-6 and 
Blimp-1 display opposing roles in the specification of mSP and mDP DCs in the intestinal 
lamina propria.
Results
Sirpα and CD103 define cDC subsets in the human small intestine
To characterize DC subsets in the human small intestine (SI), we prepared cell suspensions 
from lamina propria (LP) of the jejunum of patients undergoing bariatric surgery. cDCs 
were defined as CD45+Lin(CD3, CD19, CD14, CD56)−MHCII+CD11c+CD123− cells. We 
established CD103 and Sirpα as suitable markers to characterize CD11c+ cDC subsets in LP 
cell preparations. CD103, an integrin implicated in interaction of DCs with epithelial E-
cadherin, defines a major migratory intestinal cDC population in the mouse15, distinguishes 
them from CD103−CD11b+ monocyte-derived LP macrophages and has been described on 
human intestinal DCs. Sirpα (CD172a), a receptor for CD47, defined discrete subsets of 
CD103+ and CD103− cDCs (Fig. 1a). CD11b, used to subset mouse gut CD103+ DCs, was 
expressed preferentially and selectively on the Sirpα+ populations (Fig. 1b), but its staining 
was consistently weak. CD103 and Sirpα together define four populations of CD11c+ cDCs 
in the SI LP (Fig. 1a, full gating strategy in Supplementary Fig. 1). Because CD103−Sirpα− 
DCs were a minor population among LP CD11c+ cDCs, which limited our ability to 
characterize them, we do not discuss them further.
All the DC subsets expressed similar levels of HLA-DR by flow cytometry, but they varied 
in the expression of other maturation and costimulatory molecules (Fig. 1b). CD103+Sirpα+ 
(hDP) DCs expressed high amounts of CD86 and CD83, while CD103−Sirpα+ DC had 
intermediate expression (Fig. 1b). CD103+Sirpα− hSP DCs had low expression of the 
costimulatory molecule CD86. hDP and (hSP) DCs highly expressed CD40. In contrast to 
blood DC subsets16, all gut DC subsets express CD40, albeit at varying levels. However, the 
expression of CD86 and CD80 was similar on both gut (Fig. 1b) and blood DCs12,16. None 
of the gut DC subsets expressed CD64 (Fig. 1b), a characteristic macrophage marker in both 
human and mouse (Supplementary Fig. 2a)17
To determine whether the DC subsets occupy discrete microenvironments, we carried out 
immunofluorescence studies of jejunal/small intestine frozen sections. All the CD103-Sirpα-
defined DC subsets were present in the LP within the villus core (Fig. 1c). Histology and 
cell suspension analysis showed that hDP DCs were the dominant subset in the jejunal LP of 
most patients (Fig. 1c,d). In two patients whose jejunal tissue presented a hyperemic 
phenotype indicative of inflammation, CD103−Sirpα+ DCs were dramatically increased in 
frequency and comprised the majority of CD11c+ DCs (Fig. 1d). The relative representation 
of DC subsets was different in the colonic LP, where CD103−Sirpα+ and hSP DCs 
predominated (Supplementary Fig. 3). The increased frequency of hDP DCs in the proximal 
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intestine parallels an increased representation of mDP DCs in the mouse small versus large 
intestine18. Altogether these data show that the human LP contains three major DC 
populations that include CD103+Sirpα+ (hDP), CD103+Sirpα− (hSP), and CD103−Sirpα+ 
DCs.
Differential expression of chemokine receptors and integrins by LP cDCs
Similar to blood DCs in man (19 and P.W., personal observations), all cDC subsets in the LP 
exhibited high expression of mucosa associated integrin α4β7 (Fig. 2a). In contrast to mouse 
DCs, in which CCR9 expression is restricted to pDCs under homeostatic conditions20, 
CCR9 was expressed by a subset of hDP DCs (Fig. 2a) and was not detected on pDCs (not 
shown) in the human small intestine. In the mouse LP, CD11c+F4/80hiCD11b+CD103− 
macrophages have high expression of the chemokine receptor CX3CR1, whereas 
CD11c+CD11b+CD103− DCs display lower CX3CR1 expression21. Compared to human gut 
CD14+ macrophages (Supplementary Fig. 2b), which expressed high amounts of CX3CR1, 
CD103−Sirpα+ DCs showed intermediate expression of CX3CR1 and the marker was absent 
on the other DC subsets (Fig. 2a).
In the mouse, the chemokine receptor CCR6 controls the localization of 
CD11c+CD11b+DEC205− DCs in Peyer's patches22. In human LP, CCR6 was highly 
expressed on both subsets of intestinal LP CD103+ DCs (Fig. 2a), while CXCR3 was 
selectively expressed on hSP DCs (Fig. 2a). Because intestinal DCs use CCR7 to access 
lymphatic vessels23, we examined the expression of CCR7 on human lamina propria DC 
subsets. Similar to migratory mDP DCs, hDP DCs had high expression of CCR7 (Fig. 2a), 
suggesting that they may migrate via lymphatics to MLNs in vivo. Supporting this idea, hDP 
DCs were present in the MLN and expressed high amounts of CCR7 (Fig. 2b). Furthermore, 
immunohistology revealed abundant hDP DCs in the gut-draining MLN, but a complete 
absence of these DC in the appendix, which lacks afferent lymphatics (Fig. 2c, d). 
CD103−Sirpα+ and hSP subsets also expressed CCR7 (Fig. 2a), suggesting that they may 
also be able to enter lymphatics and migrate to the MLN.
The results define conserved and divergent subset expression of chemoattractant and 
trafficking programs in man vs mouse. Notably, patterns of CX3CR1 expression appear 
conserved within DC and macrophages in the gut; and CCR7 expression appears to define 
migratory subsets.
Gene expression and surface receptor profiling of human gut DCs
Next we sorted hDP, hSP and CD103−Sirpα+ subsets from human gut and carried out 
genome-wide transcriptional profiling. Differentially expressed genes were used to align the 
three human gut DC subsets with human blood and skin DC and blood monocyte 
populations as profiled previously12. Hierarchical clustering suggested a close relationship 
of gut hSP DCs with cross-presenting blood CD141+ DCs, whereas hDP DCs clustered with 
the major blood CD1c+ DC subset and CD103−Sirpα+ DCs clustered with blood monocytes, 
consistent with the possibility that they are derived from recruited monocytes (Fig. 3a).
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Although each of the clusters highlighted was significant, the association of hDP DCs with 
CD1c+ DCs by hierarchical clustering was not robust with respect to gene set selection 
criteria or clustering algorithm. We therefore assessed the pairwise correlation of gene 
expression in hDP DCs with that of individual blood and skin DC and monocyte 
populations. Three of the hDP DC samples correlated significantly (p<0.001) with blood 
CD1c+ DCs, while the other two aligned preferentially with skin CD1c+ (p<0.001), 
suggesting potential differences in tissue-variant gene expression (Supplementary Fig. 4a). 
Consistent with the clustering results, hSP and CD103−Sirpα+ DC correlated best with 
CD141+ blood DC and with monocytes, respectively (Supplementary Fig. 4a). 
CD103−Sirpα+ intestinal DC also aligned weakly but significantly with CD14+ skin DC, a 
population related to monocytes as well12.
To assess the relationship of gut DCs with blood DCs and monocytes independently of 
tissue-specific genes, we took advantage of lineage-associated gene sets developed 
previously12, from which skin and blood-specific genes were specifically excluded. We 
additionally excluded gut-specific genes (genes that differed significantly between pooled 
gut, skin and blood samples) and selected for genes whose expression differed significantly 
between gut DC subsets (see Supplementary Gene List for Fig. 3 for full gene list used). 
Using Pearson correlation, we show that hDP DCs are enriched in CD1c lineage genes as 
evident from alignment of hDP with blood CD1c+ DCs (Fig. 3b). Similarly, hSP align with 
blood CD141+ DCs in expression of CD141 lineage genes, and CD103−Sirpα+ DCs with 
blood monocytes in expression of monocyte lineage gene sets (Fig. 3b).
Blood CD141+ DCs are efficient antigen cross-presenting cells, and share phenotypic and 
functional properties with mouse cross-presenting CD8α+ lymphoid DCs12. Using a scatter 
plot of normalized gene expression we found a strong correlation between gut hSP and 
blood CD141+ DCs (Fig. 3c). The two populations shared expression of CD141, as well as 
of core cross-presenting DC signature genes, including the chemokine receptor XCR1 (Fig. 
3c) (supports migration of DCs to XCL1 expressed by CD8+ T cells), the lectin receptor 
CLEC9A (Fig. 3c, e) (mediates uptake of apoptotic cells), and the adhesion receptor 
CADM1 (Fig. 3c), (may promote induction of CTL responses24). Notably, hSP DCs 
expressed higher levels of IDO1, CLEC1A and BTLA, molecules associated with dampening 
of the immune response (Fig. 3c, f), and NLRC5 (Fig. 3c, f), a key regulator of MHC class I 
expression for controlling immune responses against intracellular pathogens25. Flow 
cytometry confirmed that hSP DCs expressed high amounts of CD141 and CLEC9A (Fig. 
3e) but lacked CLEC4A (DCIR, the 33D1 antigen), CD101, CD206 (Fig. 3e) and CD11b 
(Fig. 1b). Collectively, these results indicate a close relationship between intestinal hSP DCs 
and CD141+ cross-presenting DCs in blood and other tissues.
hDP DCs express a number of receptors, e.g. CD101, CLEC4A, CD206 and CD209 (DC-
SIGN) that have been described as markers of mDP DCs (Fig. 3c, e; and comparative 
transcriptomics analysis below). The immunoregulatory lectin receptors CLEC4A (Fig. 3e) 
and CLEC10A (data not shown) and the immunoregulatory Ig family member CD10126 
were highly expressed by hDP, but absent or poorly expressed by hSP DCs (Fig. 3e). Both 
CD101 and CLEC4A were also expressed at intermediate levels on CD103−Sirpα+ DCs 
(Fig. 3e). TLR5 was expressed by the two Sirpα+ DC subsets, but not by hSP DCs (Fig. 3e). 
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Expression of the endocytic receptors CD206, CD209 and CD207 (Langerin) was restricted 
to hDP DCs (Fig. 3e). The transcription factor IRF4 was also highly expressed in hDP, but 
absent in hSP DCs (Fig. 3e). Thus, hDP gut DCs share many phenotypic features with their 
mDP intestinal DC counterparts.
A number of genes associated with tolerance induction were preferentially expressed by 
hDP DCs, such as VSIG4, a member of the B7 superfamily and a negative regulator of T cell 
activation (Fig. 3d), IRAK3, a key inhibitor of the IRAK-NF-κB pathway in chronic 
inflammation, TGFBR2, a receptor involved in TGF-β signaling and the inhibitory receptor 
PILRA, which also serves as an entry receptor for herpes simplex (data not shown). hDP 
DCs also specifically expressed transcripts for molecules involved in regulating IL-2227, a 
cytokine that can promote pathological inflammatory response in the intestine28. These 
included the cytosolic sensor NLRP3, caspase-1, IL-18 and the soluble IL-22 cytokine 
receptor IL-22RA2 (Fig. 3f).
We assessed the genes co-regulated in gut hDP DC and blood CD1c+ subsets by comparing 
each of them to CD141+ DCs derived from the same tissue. Plotting the fold change in gene 
expression between CD1c+ and CD141+ DC in blood versus that between hDP DCs and 
CD141+ hSP DCs in the gut revealed that the majority of differentially expressed genes 
were coordinately regulated in the gut and blood DC subsets (Fig. 3d). Most of these genes 
were also coordinately regulated between skin CD1c+ and CD141+ DCs (Fig. 3d). However, 
a number of genes expressed by gut hDP and blood CD1c+ DCs, including CLEC10A, 
CLEC4A, ALOX5 and GIMAP4, were downregulated in skin CD1c+ DCs. Genes 
preferentially expressed by CD1c+ DCs in all sites (ie, by blood CD1c vs blood CD141+ 
DC, skin CD1c+ vs skin CD141+ DC, and gut hDP vs hSP DCs), included CD1c, CD1e, 
Sirpα, IgSF6, IRF4 and MS4A6A (Fig. 3d).
Gut CD103−Sirpα+ DC gene expression showed a significant correlation with that of blood 
monocytes (Supplementary Fig. 4), especially CD14+ monocytes. Importantly, 
CD103−Sirpα+ DCs fulfilled current criteria that distinguish DCs from macrophages. First, 
they expressed CD11c, but lacked the canonical macrophage antigens CD14 and CD64 (Fig. 
1b). Second, intestinal CD103−Sirpα+ DCs were as efficient as hDP DCs, and better than 
hSP DCs, at promoting T cell expansion in allogenic co-culture, a feature that distinguishes 
DCs from macrophages (Supplementary Fig. 5a). Finally, the PU.1/Mafb ratio, which 
determines whether a myeloid precursor acquires a macrophage or DC fate29 was similar in 
CD103−Sirpα+ DCs and other gut DCs, and much lower than in macrophages 
(Supplementary Fig. 5b).
Together the results establish a close relationship between intestinal hSP DCs and CD141+ 
cross-presenting DCs in blood and other tissues, and between gut hDP and the blood CD1c+ 
DC lineage. They suggest that gut CD103−Sirpα+ comprise a true DC population, likely 
derived from inflammatory recruitment of circulating monocytes. The latter hypothesis was 
consistent with the dramatic increase in the frequency of CD103−Sirpα+ DCs in the lamina 
propria isolates of two specimens with hyperemic intestinal mucosa (Fig. 1d).
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Human intestinal DC subsets in CD4+ T cell education
Intestinal DCs moderate gut immune responses in part by inducing regulatory CD4+ T cells 
(Treg)18. In humans, Treg cells are phenotypically identifiable as 
FOXP3+CD127loCD25hiCD4+ T cells30. We primed human allogeneic naïve peripheral 
blood CD4+ T cells with DC subsets sorted from lamina propria and assessed the expression 
of FOXP3, CD25 and CD127 on responding CD4+ T cells after 9 days. While both hDP and 
CD103−Sirpα+ DCs supported robust T cell proliferation, hDP DCs were the most efficient 
inducers of FOXP3+CD127lo cells (Fig. 4a, b). Co-culture with hSP DCs induced 
comparatively less T cell proliferation (Supplementary Fig. 5a) and fewer T cells 
upregulated FOXP3 (Fig. 4a).
Induction of Treg cells by mouse gut DCs is mediated in part by DC expression of aldehyde 
dehydrogenase (ALDH) activity, which produces retinoic acid for presentation to 
responding T cells7. To assess whether the differences in induction of 
FOXP3+CD127lowCD4+ T cells correlated with ALDH activity, human DC subsets were 
incubated with the fluorogenic substrate ALDEFLUOR, in the presence or absence of the 
ALDH inhibitor DEAB, and fluorescence was assessed by flow cytometry. Both Sirpα+ DC 
subsets exhibited high ALDH activity compared with Sirpα− DCs (Fig. 4c). Similarly, mDP 
DCs display the highest RALDH activity and efficiency at inducing Foxp3+ CD4+ Treg 
cells18. In the context of intestinal immune responses, DC-driven production of retinoic acid 
also imprints responding T cells with trafficking receptors for homing to the small 
intestine31. Consistent with the pattern of ALDH activity in the DC subsets, hDP DCs were 
strong inducers of CCR9 on CD4+ T cells, but all subsets of gut DCs could induce the 
receptor (Fig. 4d). In humans and mice, gut microbiota and their metabolites act via resident 
DCs at steady-state to promote IL-17 production in T cells in the SI lamina propria32,33. We 
examined the capacity of human gut DC subsets sorted from the LP to stimulate and polarize 
naïve CD4+ T cells in an allogeneic mixed leukocyte reaction. After 9 days of coculture, we 
restimulated the responding allogeneic CD4+ T cells with PMA+ionomycin and stained for 
intracellular cytokines. Lamina propria hDP and hSP DCs induced the highest frequency of 
TH17 cells (Fig. 4e), whereas CD103−Sirpα+ DCs were relatively inefficient. This result is 
consistent with the TH17-skewing capacity of mDP DCs from the small intestine9,14,18. In 
contrast, the CD103−Sirpα+ DC subset was most efficient at skewing responding CD4+ T 
cells towards IFN-γ production (Fig. 4f), similar to monocyte-derived mouse intestinal 
inflammatory DCs (CD103− CX3CR1int DCs) which are also efficient inducers of TH1 
cells34.
Differences in CD4+ T cell priming could reflect differences in steady-state cytokine 
expression by the DCs. However, genes for key cytokines involved in T cell differentiation, 
namely IL-6, IL-23, IL-12 and IL-10 were poorly expressed if at all (mean raw value <150) 
in all DCs subsets at steady-state. It will be interesting to analyze cytokine expression by 
activated DC subsets in vitro, and by DC in inflamed settings in this regard.
Comparison of mouse and human DC subsets
We next sought to compare the gene expression profiles of human and mouse gut DC 
subsets in order to further assess their relationships, and to define evolutionarily conserved 
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DC subset signatures. We identified sets of human genes or their mouse homologs that were 
differentially expressed among the three human gut DC subsets profiled here; among mouse 
gut mSP, mDP DCs and CD11b+ macrophages; and among mouse spleen CD4+ and CD8α+ 
DCs and red pulp macrophages (data from Immgen.org; see Methods). Normalized 
expression of genes common to the three gene sets above was used to cluster human and 
mouse DC and monocyte-macrophage cell types (Fig. 5a, see Supplementary Gene List for 
Fig. 5a for full gene list). Hierarchical clustering using a Euclidean distance metric indicated 
a significant similarity between hSP DCs, intestinal mSP and cross-presenting splenic 
CD8α+ DCs (cluster 1 DCs hereafter). Intestinal hDP DCs clustered with mDP and spleen 
CD4+ DCs (cluster 2 DCs; Fig. 5a). Human intestinal CD103−Sirpα+ DCs clustered with 
mouse blood Ly6c+ monocytes (Fig. 5a), supporting their relationship with human blood 
monocytes (Fig. 3a). Mouse gut CD11b+ macrophages and spleen red pulp macrophages, 
both thought to represent resident macrophages, formed a separate cluster. Transcriptomic 
data on mouse inflammatory CD103−CD11b+CX3CR1int DCs from lamina propria was not 
available and thus we did not compare their gene expression profile with human 
CD103−Sirpα+CX3CR1int DCs.
We identified genes whose expression differed at least 4 fold between the clusters for 
heatmap visualization (Fig. 5b). DC cluster 1 was enriched in transcripts belonging to a 
wide-range of functional groups, including solute carriers, inhibitory and activating ligands, 
adhesion and signaling molecules. In particular, XCR1, CLEC9A, TLR3 and CADM1 
appeared as highly conserved markers of cluster 1 (hSP, mSP, CD8α+ cross-presenting-like) 
DCs in mouse and human (Fig. 5b). Transcription factors IRF8 and BATF3, which are 
critical for the differentiation of mSP and lymphoid CD8α+ DCs, were also expressed by gut 
hSP and by human blood CD141+ DCs (Fig. 5b and Fig. 3c), suggesting conservation of 
genes regulating cluster 1 differentiation. Genes preferentially expressed by cluster 2 DCs 
included the canonical CD4+ DC marker Clec4a (33D1 antigen), CD101 (Igsf2) and the 
transcription factor IRF4, implicated in CD4+ and mDP DC development in the mouse (Fig. 
5b). Cluster 2 DCs also shared preferential expression of ABCB1 (an ATP dependent 
xenobiotic efflux transporter, variants of which are associated with inflammatory bowel 
disease), and were enriched in genes that enhance leukocyte motility, including the Rac 
GTPase activating proteins Vav2 and Dock4. A number of genes were shared by human and 
mouse monocytes and by CD103−Sirpα+ DCs, such as the IFN induced anti-viral protein 
IFITM2 and the C5A receptor, and distinguished them from DCs derived from committed 
DC precursors. Identification of core tissue and species-independent signature genes for 
CD103−Sirpα+ DCs must await gene profiling of mouse intestinal inflammatory (monocyte-
derived) DCs.
Interestingly, a number of genes shared by intestinal hDP DC and cluster 3 (CD103−Sirpα+ 
DCs/monocyte group) were less well conserved in expression by spleen and MLN CD4+ 
DCs. These genes, which include Fc receptors, EMILIN2, ALOX5, THBS1, C3AR1, PRDM1, 
CLEC10A and VWA5A, may be induced in cluster 2 and 3 DC in response to the gut 
inflammatory environment. Thus the results support the conservation of core lineage-
specific gene signatures, but also reveal conserved responses to local tissue environments.
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Conserved signatures of SP and DP intestinal DCs in mouse and man
We next looked more closely at conserved transcriptional profiles of SP vs DP DCs. Among 
∼700 genes that differed at least 2 fold between human or mouse SP versus DP DCs, only 
84 showed coordinate up- or downregulation in both species: 18 genes were elevated in both 
mouse and human SP versus DP DCs; and 66 genes were more highly expressed in the DP 
DC populations (Fig. 5c and Supplementary Table 1). Interestingly, differential expression 
of 14 of these genes was exclusively seen in the gut: these genes were either not 
differentially (<2 fold) expressed or were discordantly regulated between cluster 1 and 
cluster 2 DC subsets in lymphoid organs or skin; and all but one (GYPC) of these genes 
were expressed more highly in DP than SP DCs. These 14 genes (Supplementary Table 1, 
bold) include genes encoding chemokine receptor CCR1, activation-associated migration 
regulator CD69, inhibitory receptor PILRA, IL13RA1, as well as transcription factor 
Blimp-1 discussed below. Together, the results show that genes conserved in their 
differential expression by SP vs DP intestinal DC comprise both core signature genes 
distinguishing cluster 1 from cluster 2 DC, as well as genes whose differential expression is 
gut-selective. They also suggest that DP and other cluster 2 lineage DCs may be more 
responsive to local (tissue-specific) environmental imprinting than cluster 1 lineage DC.
Differential expression of Bcl-6 and Prdm1 in DC subsets
We hypothesized that transcription factors (TF) that were differentially expressed between 
intestinal DP versus SP DCs in both mouse and man might contribute to conserved gut DC 
specialization. Only seven TF showed conserved differential expression: IRF8 and Bcl-6 
were preferentially expressed in SP DCs compared to DP DCs, while IRF4, Prdm1, ZEB2, 
HIVEP2 and FoxN3 were more highly expressed in DP DCs (Fig. 6a). Id2 and BATF3, also 
implicated in intestinal DC development, were elevated in human and mouse SP versus DP 
DCs, but did not meet the criteria of 2-fold differential expression in both species (data not 
shown). The roles of ZEB2 or FoxN3 in hematolymphoid cell development remain unclear, 
while Bcl-6 and Blimp-1 (encoded by Prdm1) are transcriptional repressors with counter-
regulatory roles in effector B and T cell fate determination35,36. Bcl-6 is downregulated by 
Blimp-1 in both lymphoid lineages37. Bcl-6 expression was highest in SP LP DC, and was 
preferentially expressed by cross-presenting (SP or CD8α+) DCs versus CD11b+ DCs across 
all tissues investigated (Fig. 6b). Prdm1 had an overall low expression in CD11b+ splenic 
DCs, and high expression in DP intestinal DCs (Fig. 6b).
In line with gene expression data, flow cytometry showed BCL-6 protein expression was 
higher in hSP DCs compared to hDP DCs (Fig. 6c). We also analyzed Bcl-6 expression 
using YFP-Bcl-6 reporter mice. In the small intestine LP, mSP DCs expressed YFP-Bcl-6, 
whereas the mDP DCs showed no Bcl-6-reporter expression. However, mLN-resident mDP 
DCs, as well as mSP DCs were both YFP-positive (Fig. 6d, e). Moreover, all DCs in the 
spleen and peripheral lymph nodes (pLN) expressed Bcl-6-YFP (Fig. 6f), albeit lower than 
SI LP mSP DCs or mLN mSP DCs. CD8α+ DCs expressed more Bcl-6-YFP than CD8α− 
(CD11b+) DCs, but this difference was more prominent in spleen than pLN DCs. Taken 
together, high Bcl-6 expression marked developmentally and functionally related mSP and 
CD8α+ DCs.
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Using reporter mice expressing YFP under control of the Prdm1 promoter, we detected high 
expression of Prdm1-YFP in mDP DCs in intestinal lamina propria DCs, while mSP DCs 
were YFP-negative (Fig. 6d, e). The difference in expression was less pronounced in mLN 
DCs, where mLN mSP DCs expressed Prdm1-YFP, although less than mDP DCs. 
CD11b+CD103− DC in the mLN (which represent a DC population unrelated to LP 
CD11b+CD103− macrophages38) did not express Prdm1-YFP. We did not detect Prdm1-
YFP expression in steady-state spleen or pLNs (Fig. 6f), consistent with the low constitutive 
Prdm1 expression in spleen DCs (Immgen.org). This suggests that Bcl-6 could contribute to 
DC specification across all organs tested, whereas Blimp-1 might have a selective role in the 
specification of the mDP intestinal DC subset at steady-state.
Blimp-1 and Bcl-6 have opposing roles in DC subset specification
To investigate the role of Bcl-6 in DC fate determination we assessed DC subsets in Bcl-6-
deficient, heterozygous and wild-type littermate mice. Phenotypically healthy Bcl-6-
deficient mice and wild-type mice had similar frequencies of plasmacytoid DCs versus total 
cDCs among CD11c+ MHC class II+ DCs within the mLNs (Fig. 7a) and other lymphoid 
tissues (data not shown), but Bcl-6-deficient mice displayed a specific loss of antigen cross-
presenting DC subsets including the mSP DCs in mLNs, small intestinal LP and colon (Fig. 
7b), and CD8α+ DCs in the spleen and pLN (Fig. 7c). To determine whether Bcl-6 acts cell-
intrinsically to control DC development, heterozygous CD45.1/CD45.2 hosts were 
reconstituted with a mixture of CD45.2+ Bcl-6-deficient and CD45.1+ wild-type bone 
marrow (Supplementary Figure 6). In these chimeric mice, mSP cDCs were derived almost 
exclusively from wild-type bone marrow, whereas Bcl-6-deficient and wild-type progenitors 
contributed equally to mDP DCs (Fig. 7d, f). Similarly, CD8α+ cDCs in pLNs and spleen 
were derived primarily or exclusively from wild-type donors (Fig. 4e), whereas both Bcl-6-
deficient and wild-type donors contributed to CD8α− lymphoid organ DCs. Taken together, 
this suggest that Bcl-6 has a critical and cell intrinsic role in the specification or survival of 
major classes of cross-presenting DCs.
To assess the role of Blimp-1 in intestinal DCs, we generated DC-specific Blimp-1-deficient 
mice by crossing CD11c-driven Cre-recombinase-expressing mice with mice carrying a 
floxed stop cassette in front of the prdm1 gene (called DC-BlimpKO from here on)39. DC-
BlimpKO mice had a higher percentage of mSP DCs in the mLNs, with a corresponding 
decrease in mDP DCs (Fig. 8a). The relative loss of mDP DCs was more pronounced in the 
intestinal LP, while the percentages of mSP DCs among total CD11c+ cells in the LP were 
similar in DC-BlimpKO and littermate control mice. The ratio of mDP to mSP DCs was 
reproducibly decreased in DC-BlimpKO vs. WT mouse SI and mLN (Fig. 8c). Consistent 
with its pattern of expression, DC-specific Blimp-1 deficiency had no significant effect on 
the relative representation of DC subsets in spleen and pLNs (Fig. 6 and Fig. 8b). Similarly, 
Blimp-1 deficiency had no effect on DC subsets in the colonic LP, where mDP DCs are a 
minor population (data not shown). Thus, Blimp-1 and Bcl-6 reciprocally and cell-
intrinsically control SP and DP DCs in the small intestine.
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Discussion
This study defines three major cDC subsets in the human small intestine, relates them to 
mouse DC subsets to elucidate evolutionarily conserved and divergent phenotypic and 
functional properties, and identifies novel roles for the transcriptional regulators Bcl-6 and 
Blimp-1 in DC development and specialization. CD103+Sirpα− (hSP) DCs align with the 
human and mouse cross-presenting DC lineage, and share preferential expression of Bcl6 
which we show contributes to differentiation of this lineage. CD103+Sirpα+ (hDP) DCs 
appear related to the human CD1c+ DC lineage, and display functional, phenotypic and 
transcriptomic similarities with mouse CD103+CD11b+ (mDP) DCs including expression of 
Blimp-1, which we show controls intestinal mDP specification. Finally, we identify 
CD103−Sirpα+ DCs as a distinct subset related to blood monocytes and with characteristics 
similar to those of mouse monocyte-derived CD103− CX3CR1int inflammatory DCs.
Both transcriptomic and phenotypic analyses confirm the close relation of hSP intestinal 
DCs to antigen cross-presenting DC lineages, including CD141+ DCs in man and CD8α+ 
lymphoid tissue and CD103+CD11b− (mSP) intestinal cDCs in the mouse. hSP express 
CADM1, XCR1 and CLEC9A, molecules with important roles in cross-priming CD8+ T 
cells: CLEC9A is involved in sensing and endocytosis of dead cells40, XCR1 mediates 
cross-talk with XCL1-secreting CD8+ T cells41 and CADM1 engages with CRTAM on 
CD8+ T cells42 and promotes IL-22 production43. hSP DCs also preferentially (compared to 
hDP DC) express transcripts for BATF3 and IRF8, genetic factors that drive development of 
the CD8α+ DC lineage in the mouse.
Comparative transcriptional analyses suggest a relationship between human gut DP DC and 
CD1c+ DC in human blood and skin. These DC populations also share expression of 
lineage-associated surface antigens including CD1c itself. However, in contrast with the 
clear correlation of gene expression between hSP DC and their blood CD141+ DC 
counterparts, the transcriptional alignment of hDP and CD1c+ DC was robust only when 
tissue-specific genes were eliminated from analysis. These observations suggest that, CD1c+ 
lineage DCs may be more sensitive than CD141+/hSP cross-presenting DCs to local 
environmental programming44.
hDP also align phenotypically and functionally with mouse DP intestinal DCs and, more 
distantly, with mouse lymphoid tissue CD4+ DC. hDP and mDP intestinal DC similarly 
induce TH17 and Treg, and both express CLEC4A, CD101, and TLR5. These conserved 
molecules regulate cytokine production and autoimmunity26,45, and likely mediate 
evolutionarily critical roles in intestinal immune homeostasis. Our comparative genomics 
analysis also revealed conserved mouse and human DP DC expression of transcriptional 
regulators IRF4, recently implicated in CD4+ DC and mDP development9, and Prdm1, 
shown here to selectively control intestinal mDP specification.
Our findings also identify CD103−Sirpα+ intestinal DCs. In two patients with hyperemic 
jejunal mucosa, there was an increase in this CD103−Sirpα+ DC population consistent with 
their recruitment or expansion in inflammation. Transcriptomic similarities between 
CD103−Sirpα+ DCs and human and mouse blood monocytes lead us to propose that they 
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may develop from monocytes recruited in response to gut inflammation, similar to a recently 
described mouse CX3CR1int cDC34. CD103−Sirpα+ DCs and mouse CX3CR1int cDCs both 
induce efficient CD4+ T cell proliferation and promote T cell IFNγ production. Given the 
diversity in CX3CR1+ populations in the mouse, we cannot of course exclude heterogeneity 
within the CD103−Sirpa+ CX3CR1int or indeed the other populations studied here. Further 
investigation of CD103−Sirpα+ DCs in colitis and other intestinal inflammatory conditions 
is warranted. Developmental relationships of CD103−Sirpα+ DCs with CD14negCD11cneg 
anergic macrophages46 need further investigation.
Interestingly, our analyses of DC in gut associated lymphoid tissues suggest that both hSP 
and hDP subsets can access the draining mesenteric LN. hDP also display the highest 
amounts of CCR7 and express genes associated with enhanced cell motility: thus, as 
proposed for mouse mDP, they may be a principal migratory subset that can transport gut 
antigenic and environmental signals to lymph nodes. hSP DCs express less CCR7 than hDP 
DCs: this may suggest a difference in relative efficiency of exit, but chemokine receptors 
can be rapidly modulated. Significant if low expression of CCR7 by Sirpα+CD103− DCs 
suggests that they may also have the capacity to migrate to draining LN.
We show that Bcl-6 is more highly expressed in human and mouse SP DCs than in DP DCs, 
and in lymphoid tissue cross-presenting DCs as well; and that it plays an important role in 
development of these cross-presenting DC populations. Previous studies suggested an 
overall reduction in mature cDCs in the absence of Bcl-647, a finding we could not confirm 
in healthy Bcl-6 deficient mice. In contrast to Bcl-6, Prdm1 is most highly expressed by 
small intestinal DP DCs, and this expression correlates with the preferential effect of 
Blimp-1-deficiency on small intestinal DC development in our study. Surprisingly, 
expression is significantly higher in LP mDP DCs than in mDP DCs in the mLN, even 
though mLN mDP DCs are thought to represent recent migrants from the LP48. This raises 
the possibility that Prdm1 is actively and potentially reversibly regulated by the local 
environment in the small intestines, contributing to its predominant effect on SI mDP DCs. 
Prdm1 expression is even lower, and Blimp-1 reporter expression undetectable, among 
CD8α−CD11b+ DCs in spleen and CD103−CD11b+ DCs in the mLN, correlating with a lack 
of significant effect of Blimp-1 deficiency on these populations in our study. These results 
suggest a selective role for Blimp-1 in the specification and fate of mDP DCs within the 
small intestines. Indeed, even colon mDP DCs expressed little Blimp-1-YFP and were 
apparently unaffected by Blimp-1 deficiency. Blimp-1 has also been implicated in DC-
intrinsic tolerance maintenance39, and it may therefore contribute to intestinal immune 
homeostasis by modulating DP DC responses as well as their numbers. Although not studied 
here, Prdm1 is also highly expressed in subsets of skin DCs and in CD11b+CD103− 
mononuclear phagocytes in the SI LP (data not shown): a role for Blimp-1 in these cells 
should be investigated. Our results suggest that Bcl-6 and Blimp-1 play key roles in an 
evolutionarily conserved transcription factor network that has evolved to control terminal 
fate decisions within each of the major lineages involved in the adaptive immune response.
In conclusion, we have characterized the dendritic cell network in the human small intestine, 
and have defined developmental parallels with the mouse DC system. The findings lay a 
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framework for investigating the function of gut DC subsets in intestinal immunity and in 
inflammatory conditions such as food allergies, IBD, and gastritis.
Online Material and Methods
Preparation of LPMCs
LPMCs were isolated from resected jejunal/colon specimens using modification of 
previously described technique49. Briefly, the mucosa was dissected free from the 
muscularis in the tissue plane of sub-mucosa using fine scissors. The dissected mucosa was 
incubated in calcium and magnesium-free HBSS (Cellgro) containing 5% heat-inactivated 
fetal bovine serum and 1mM DTT (Sigma-Aldrich) to remove mucus. The epithelial layer 
was removed by incubating the mucosa three times for 15min in HBSS containing 5mM 
EDTA at 37°C with stirring. Tissue was collected and treated with Liberase TL (25μg/ml, 
Roche) containing HBSS for 30 minutes at 37°C. The remaining tissue was mashed and 
cells were collected by centrifugation (10min, 4°C, 400g). The mononuclear cells were 
subjected to centrifugation in a 70%/44%/20% percoll density gradient to separate 
lymphocytes from contaminating epithelial and stromal cells. All human tissue samples 
were de-identified and approved by IRB.
DC Enrichment
cDCs were enriched from LPMCs by negative selection with biotin conjugated mouse anti-
human lineage marker mAbs against CD3, CD14, CD16, CD19, CD56 and glycophorin, 
followed by their removal using biotin negative selection cocktail (19153, Stemcell 
Technologies). Enriched DCs were labeled with antibodies and sorted using BD FACS Aria 
III (100μm nozzle, BD Biosciences). For microarray studies, the DCs were collected directly 
into RLT buffer (Qiagen).
Antibodies and Flow Cytometry
Anti-HLA-DR (L243), anti-CD103 (Bly7), anti-CD123 (6H6), anti-CD3 (OKT3), anti-
CD14 (61D3), anti-CD16 (3G8), anti-CD83 (HB15e), anti-CD101 (BB27), anti-IRF4 (3E4), 
and anti-CD40 (5C3) were purchased from eBioscience. Anti-CLEC4A (I3-612), and anti-
CD11b (ICFR44) were obtained from BD Biosciences. Anti-CD141 (M80), anti-CD172a 
(SE5A5), anti-CD11c (Bu15), anti-CD56 (MEM-188), anti-CLEC9A (8F9), anti-CX3CR1 
(2A9-1), anti-CXCR3 (TG1) antibodies were purchased from Biolegend. Anti-CD207 
(DCGM4) antibody was obtained from Immunotech. Anti-CCR7 (150503) antibody from 
R&D Systems. Anti-α4β7(Act-1) and anti-CCR9 (3E3) were produced in our lab from 
hybridomas. BCL-6 was stained with APC-conjugated αBCL-6 (clone K112-91) from BD 
Biosciences using the Foxp3 Staining Buffer Set from eBioscience. The cells were stained in 
with combinations of above listed fluorochrome-conjugated antibodies. Lamina propria 
leukocytes were incubated at 37° C for two hours prior to staining when indicated to allow 
cells to reexpress internalized chemokine receptors: this procedure was important for 
detection of CCR9. Staining was analyzed using BD LSRFortessa and FlowJo software 
(Tree Star Inc). ALDH activity was determined using the ALDEFLOUR staining kit 
(STEMCELL Technologies Inc.) according to the manufacturer's protocol as modified50.
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Microscopy
Appendix and jejunum samples were placed in Tissue-Tek (Sakura) and frozen at −80°C. 
Cryosections of acetone-fixed tissue were incubated sequentially with rabbit anti-human 
CD11c (Epitomics), Dylight 549 donkey-anti-rabbit IgG (Jackson Immunoresearch), mouse-
anti-human Sirpα (SE5A5), Dylight 488 donkey-anti-mouse IgG (Jackson 
Immunoresearch), mouse serum, and Alexa 647 conjugated mouse-anti-human CD103 
(eBioscience). Staining was imaged on an LSM 710 confocal microscope (Carl Zeiss).
In vitro Treg and CD4+ T helper differentiation
Naïve CD4+ T cells (5×104 cells/well) were cultured with small intestine DC (1 × 104 cells/
well) subsets in Yssel's medium with 2% human serum. After 9 days, cultured cells were 
harvested and analyzed for intracellular Foxp3 expression by flow cytometry. Cocultured 
cells were re-stimulated for 6 hours with PMA (50ng/ml; Sigma) and ionomycin (500ng/ml; 
Sigma) in the presence of GolgiStop (BD Pharmingen). CD4+ T cells producing IFNγ and 
IL-17 were analyzed by flow cytometry.
Statistical analysis
The statistical significance of differences between the two sets of data was assessed by 
Student's t-test unless stated otherwise. Analytic methods for significance of differential 
gene expression are indicated in the text. Significance of clusters was determined by 
modified bootstrap resampling51.
Microarray Analysis
All intestinal DC samples generated in this study are deposited in GEO, accession code 
GSE50380. RNA was isolated from the sorted DC subsets using Qiagen RNeasy Plus Micro 
kit. 5-20ng of total RNA from each sample was used for amplification, labeling, and 
hybridization by Expression Analysis, Inc (Durham, NC). Hybridization was performed on 
Affymetrix Genechip® Human Gene 1.0 ST Array. GeneSpring GX 11.5 and Partek 
Genomic Suite (6.6) were used for processing and analyzing the data. Genespring 
preprocessing and default normalization (RMA-16) was applied to each dataset [i.e., 
separately for Illumina data from Haniffa et al12 (NCBI GSE35458); for our human 
Affymetrix Human Gene 1.0 ST Array data (to be deposited); and for mouse Affymetrix 
data from Immgen.org (NCBI GSE15907)] for the populations included in the specific 
analyses. Translation of mouse gene lists to their human homologs was performed in 
Genespring. For analyses involving data from different platforms, normalized gene 
expression values were exported from Genespring and combined for analysis in Partek after 
removal of gene duplicates in Excel.
For clustering and correlation analyses, genes that discriminate the studied DC or monocytes 
subsets within each tissue type were selected. For human subset comparisons, genes with the 
15% most variable expression between subsets isolated from blood or skin, and between the 
gut DC subsets, with expression above threshold values (>120 for Affymetrix data; >160 for 
Illumina data) by at least one subset in each tissue, and differing significantly in expression 
between the three gut DC types (p<0.01 ANOVA) were used. The 535 genes so selected are 
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listed in the Supplementary Gene list document as Gene List for Fig. 3a and Supplementary 
Figure 4.
To assess the relationship of gut DC to blood DC and monocytes independently of tissue-
specific genes, blood vs skin-specific gene-depleted CD1c+ DC-, CD141+ DC-, and CD14+ 
monocyte- lineage gene sets from Haniffa12 were filtered as follows to remove gut-specific 
genes: Samples isolated from each tissue type (skin, blood or gut) were pooled, and genes 
that discriminated gut, blood or skin pools (P<0.05 ANOVA) were excluded. Samples 
included for these analyses were those presented in the cluster dendrograms. Remaining 
genes were filtered for differential expression by the gut DC subsets (P<0.05), yielding 
common (tissue-specific-gene depleted) lineage-associated gene sets that are presented as 
lineage associated genes for Fig. 3b in Supplementary Gene lists for Figure 3. CD1c+ DC 
lineage-associated genes were used to compare CD1c+ blood DC with gut DC subsets; and 
the CD141+ DC- and CD14+ monocyte- lineage gene sets to compare our samples with 
CD141+ DC and CD14+ monocytes, respectively (Fig. 3b).
For display of the correlation of genes discriminating blood CD1c+ vs CD141+ DC with 
those discriminating human gut CD103+ DC subsets (Fig. 3d) genes whose mean expression 
differed at least two fold between gut CD103+Sirpα+ vs CD103+Sirpα− DC, and also 
between CD1c+ vs CD141+ blood DC were selected (246 genes, Fig. 3d, Supplemental 
Gene List for Fig. 3).
For mouse/human comparisons, human genes or their mouse homologs differentially 
expressed (top 15% most diverse) a) among the three human gut DC subsets, b) among 
mouse gut CD103+CD11b−, CD103+CD11b+ DCs and CD11b+ macrophages, and c) among 
mouse spleen CD4+ and CD8α+ DCs and red pulp macrophages were selected. Genes 
common to the three gene sets above were further selected for threshold expression (>120 
by at least one mouse and one of the human DC subsets clustered) and for significance in 
comparisons of human gut DC subsets (p<0.01, Benjamini-Hochberg corrected), and were 
then used to cluster human gut DC (replicate samples) with mean expression profiles of 
human and mouse DC and monocyte/macrophage cell types (Fig. 5a). The 455 genes so 
selected are listed in Supplementary Gene List for Fig. 5a. Genes that differed significantly 
(p<0.01, ANOVA) and by at least 4 fold between the three DC or DC/monocyte clusters 
defined in Fig. 5a were used for the heatmap in Fig. 5b.
For generation of gene-expression datasets comparing human and mouse intestinal DP 
versus SP DCs (Fig. 5c and transcription factor expression, Fig. 6a), mouse gene expression 
data from the Immgen Consortium38 were obtained from the NCBI GEO website 
(GSE15907). Gene lists were created in Genespring as follows: Genes were filtered by 
expression value (at least one replicate in either subset had to show a raw value above 120), 
followed by statistical analysis to exclude samples with excessive variability (unpaired, two-
tailed t-test between both DC subsets >0.05, uncorrected). We then filtered on probes that 
were at least 2-fold differentially expressed between the mSP and mDP DC subsets. The 
same filtering criteria were applied to our human datasets to identify genes differing at least 
2 fold between hDP and hSP DCs. The mouse gene list was then translated into the human 
experiment in Genespring. The intersection of both lists was used for the ratio-depicting 
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scatter plot, generated in Partek Genomic Suite. For transcription factor identification, we 
used GO Term 0003700: sequence-specific DNA binding transcription factor activity.
Mice
Bcl-6-deficient (Bcl-6-KO) mice were provided by A. Dent (Indiana University) and 
maintained and bred in specific pathogen-free conditions in the animal facility of Veterans 
Affairs Palo Alto Health Care Systems (VAPAHCS). YFP-Bcl-6 mice52 were provided by 
Dr. T. Okada (RIKEN, Japan), and Prdm-1-YFP mice53 were provided by Eric Meffre (Yale 
University). Both strains were bred and maintained at UCSF. DCBlimpKO mice and control 
mice were bred in the animal facility of The Feinstein Institution for Medical Research 
(FIMR) under specific pathogen-free conditions and repeats were performed with mice bred 
at VAPAHCS. All animal work was approved by the IACUC committee at the VAPAHCS, 
or by relevant animal care committees at the collaborating institutions.
Mouse lymphocyte isolation
Spleens, peripheral (inguinal, axillary and brachial), and mesenteric LNs were isolated and 
digested with RPMI media containing 5% FCS, 0.5 mg/ml of collagenase IV (Sigma 
Aldrich) and 1 unit/ml of DNaseI (Sigma) for 30 minutes at 37°C and made into single cell 
suspension. For the isolation of lamina propria residing dendritic cells from small intestine 
and colon, full-length SI (with Peyer's Patches removed) and colon were cut open 
longitudinally and rinsed twice in HBSS (without Ca2+ and Mg2+) with 2% FCS and cut into 
small pieces. After 1mM EDTA treatment for 40 minutes total to release the epithelium, 
tissues were digested in 10 ml RPMI containing 5% FCS and 0.5 μg/ml of collagenase IV 
(Sigma C2139) at 37°C for 15 minutes, 3 times. Supernatant containing LP cells was 
collected. Mononucleated cells from both colon and SI LP supernatant were isolated by 
gradient separation with 40% and 70% Percoll solutions (GE, 17-0891-01) at 2500 rpm for 
15 minutes at room temperature. Cells of interest were located at the interface.
Flow-cytometry on mouse cells and analysis
Cells were first blocked with FACS buffer (PBS with 0.5% BSA) containing 1μg/ml 
αCD16/CD32 (clone 93, eBioscience). The following antibodies were purchased from either 
eBiosciene, Biolegend or BD Biosciences and used for staining: αCD3-PECy7/AF780 
(145-2C11), αCD19-PECy7/AF780 (ID3), αNK1.1-PECy7/AF780 (PK136), αB220-
PECy7/AF700/AF780 (RA3-6B2), αMHCII-AF700/AF780 (M5/114.15.2), αCD11c-
PB/PE-Cy7 (N418), αCD103-PE/Fitc/APC (M290), αCD11b-PerCP-Cy5.5 (M1/70), 
αCD8α-APC/V500 (53-6.7), αCD45.1-APC/A780 (A20), αCD45.2-FITC (RA3-6B2), 
αCLEC4A-PE/APC (33D1), αCD101-PE (Moushi101), αTLR3-APC (11F8). Dead cells 
were excluded by propidium iodide staining (Sigma). Flow cytometry data was acquired on 
either a LSRII or a Fortessa (BD), using Diva software (BD). Further analysis was 
performed using FlowJo from Treestar. Statistics of all flow cytometry-based data were 
calculated with the unpaired Student's t-test using GraphPad Prism.
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Generation of mixed bone marrow chimeras
Donor bone marrow cells were collected from femurs and tibias and bone marrow was 
flushed out using a 27G needle. After red blood cell lysis, cells were counted and 5 × 106 
cells total were injected into lethally irradiated recipients (1000 Rad). To ensure equal 
engraftment by different donor cells, following groups were set up: Bcl-6 knockout-derived 
on CD45.2 allogeneic background with wild type-derived donor cells on a CD45.1 
background as experimental group and wild type-derived donor cells on both backgrounds 
as a control group. For the latter, we used littermates from Bcl-6 knockout mice as CD45.2 
wild type mice to ensure for proper engraftment by this strain. At least six different mixed 
bone marrow groups were set up with successful engraftment from both donor cell 
populations in all groups tested.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Human small intestine lamina propria DC subsets can be distinguished using CD103 and 
Sirpα
a) Flow cytometry of lamina propria DCs subpopulations gated on live CD45+ lineage 
(CD3, CD14, CD16, CD19, and CD56) negative MHCII+ cells. Representative dot plot from 
fifteen donors is shown here.
b) Flow cytometry of lamina propria DC stained with CD11b, HLA-DR, CD86, CD40, 
CD80, CD83 and CD64. Representative results of three to five independent experiments are 
shown.
c) Confocal microscopy (X63) of small intestine villus stained for Sirpα (green), CD11c 
(red) and CD103 (blue), illustrating intermingling of CD103+Sirpα− (hSP), CD103+Sirpα+ 
(hDP), and CD103−Sirpα+ CD11c+ cells within the lamina propria. Representative of 4 
donors.
d) Relative frequency of intestinal DC subsets among live CD45+lin−HLADR+CD11c+ cells 
in 15 donors. Open symbols denote two patients with hyperemic epithelium with increased 
percentage of CD103−Sirpα+ DCs.
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Fig. 2. Mucosa associated chemokine receptors and integrins expressed by LP DCs
a) Flow cytometry of lamina propria mononuclear cells stained for the indicated chemokine 
receptors and integrins. The open (black lines) histograms show the staining profile with 
indicated antibody while filled (grey) histograms show isotype control staining. Data from 
one of 3-6 experiments with similar results.
b) Flow cytometry of CD103+Sirpα+ (hDP) DCs from MLN assessing expression of CCR7. 
Representative result of three independent experiments is shown.
c) Three-color immunofluorescence staining for Sirpα (green), CD103 (blue), and CD11c 
(red) in cryosections of appendix (X63). Representative result of three independent 
experiments for (c) and (d) is shown.
d) Same as in c) for MLN. CD103+Sirpα+ (hDP) CD11c+ DCs are present in MLN (arrows) 
but not appendix.
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Fig. 3. Transcriptomic and phenotypic comparison of DC subsets in human gut and blood
a) Hierarchical clustering by correlation of gut, blood and skin DC subsets based on profiles 
of differentially expressed genes (see online Methods). Significance of clusters of interest is 
indicated (**p<0.01; *p<0.05).
b) Alignment of blood CD1c+ DCs, CD141+ DCs and CD14+ monocytes with gut DC 
populations. Data represent pairwise correlation of replicate gut DC samples with mean gene 
expression profiles of blood CD1c+ DCs, CD141+ DCs or CD14+ monocytes from 
Haniffa12, using CD1c DC-, CD141 DC- and CD14 monocyte lineage-associated gene sets 
respectively. Shown with mean and SEM. *=Positive correlation, p<0.01, based on 99% 
confidence limits.
c) Scatter plot of normalized average gene expression values between gut hSP and blood 
CD141+ DCs.
d) Comparison of differential gene expression by gut and blood DC subsets. Genes that 
differ at least two fold in expression between the two gut DCs, hDP and hSP, and also 
between blood CD1c+ and CD141+ DC are plotted. Colors indicate genes up (red) and down 
(blue) in skin CD1c+ versus CD141+ DCs. Most genes display coordinate regulation 
between CD1c+ vs CD141+ DC subsets in all three tissues.
e) Flow cytometry of DC subsets stained for the indicated receptors and transcription 
factors. CD103+Sirpα+ (hDP) DCs (red), CD103+Sirpα− (hSP) DCs (black), CD103−Sirpα+ 
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DCs (blue), and representative control staining (grey). Data shown are representative of 
results from 4-5 donors.
f) Relative expression of BTLA, BATF3, TAP1, NLRC5, NLPR3, and IL-22RA2 by gut DC 
subsets. Arbitrary units (Affymetrix expression) with SEM of the biological replicates 
shown.
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Fig. 4. Human intestinal DC subsets in CD4 T cell education
a) Flow cytometry of CD4+ T cells activated by incubation for 9 days with allogeneic sorted 
gut DC subsets. CD4+ T cells were stained for CD25, CD127, CD4 and FOXP3. Shown are 
plots of FOXP3 versus CD127 for CD25hi CD4 cells (black dots) and for CD25lo CD4 cells 
(grey density contours). Gates for FOXP3 were set based on isotype control. Numbers 
indicate CD25hi FOXP3+CD127lo Treg cells as percentage of total CD4+ T cells. 
Representative for four experiments.
b) Composite data of four experiments expressed as FOXP3+CD127lo cells as percentage of 
total CD4+ T cells, * p<0.05 Mann Whitney, mean ± SEM.
c) RALDH activity in the three gut DC subsets assessed by ALDEFLUOR assay. Fold 
change in mean fluorescence intensity (MFI) of ALDEFLUOR staining in the presence or 
absence of the RALDH inhibitor DEAB. Representative of six independent experiments.
d) Flow cytometry of CD4+ T cells activated as in a). FACS plots illustrate representative 
CCR9 and α4β7 induction. Composite data of three experiments are presented in the bar 
graphs. Middle: percent of CD4 cells staining for α4β7, with SEM. Right: percent of CD4 
cells staining for CCR9 (mean±SEM).
e,f) Staining of IL-17 and IFNγ in CD4+ T cells differentiated in vitro by co-culturing naïve 
CD4+CD45RA+CD25− T cells with sorted lamina propria DC. Numbers (left panel) denote 
percent positive, and are from one of three independent replicates included in the graph at 
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right (symbols indicate different replicates). Data in graph are shown with mean ± SEM. * 
p<0.05, paired t-test.
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Fig. 5. Transcriptomic relationship between human intestinal DC and mouse DC subsets
a) Hierarchical clustering illustrates transcriptional alignment of human intestinal DC with 
mouse DCs from gut and lymphoid organs. Euclidean distances were computed using genes 
selected as differentially expressed (top 15% most diverse in comparisons of cell types 
isolated from each organ); mean expression >120 for at least one mouse and one human 
population; and differentially expressed between human gut DC subsets (P<0.05). 
Significant clusters (P<0.01) of interest are highlighted. GEO accession code for human 
intestinal microarray data: GSE50380; for others see materials and method section.
b) Heat map illustrating expression of transcripts that are most differentially expressed 
(ANOVA P<0.01, at least 4 fold difference) by the three groups of DCs or DCs and 
monocytes defined by the highlighted clusters in the dendrogram in 5a.
c) Scatterplot of the ratios of the normalized averaged values between SP and DP DCs of 
mice against men. Depicted genes are at least 2-fold differentially expressed between SP and 
DP in both species. Mouse gene expression data were obtained from the NCBI GEO website 
(GSE15907) and originate from the Immgen Consortium38. All probes were selected for 
>120 expression value in all replicates in at least one sample, and for an uncorrected p-value 
of <0.05 between the two subsets in each species.
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Fig. 6. Differential expression of Bcl-6 and Blimp-1 in DC subsets
a) VENN diagrams of all transcription factors at least 2-fold differentially expressed by 
human intestinal SP vs DP DCs or by mouse SP vs DP DCs. Genes within the intersections 
showed conserved SP or DP-selective expression in mice and humans.
b) Microarray data for pdrm1 (Blimp1-encoding) and Bcl-6 genes in small intestinal SP 
versus DP DCs. Bar graphs show the mean and SEM of raw expression values.
c) BCL-6 staining on human intestinal DCs. hSP DC gates and data are shown in orange, 
hDP in blue, non-stained control in gray. Bar graph shows the MFI of BCL-6 staining in 
each subset (n=3, p<0.05 paired t test.
d) Expression of a YFP-Bcl-6 and a Prdm1-YFP reporter by gut associated mouse cDCs. 
Contour plots show gating strategies. Pre-gated on live, lineage negative (CD3, CD19, 
NK1.1), CD11chi, MHCIIhi cells. Histograms depict YFP-Bcl-6 expression in the indicated 
DC subsets (green: CD103−CD11b+, blue: mDP, orange: mSP) and a wildtype control 
(gray). Data are representative of two independent experiments (n=3).
e) MFIs for YFP-Bcl-6 and YFP-Prdm1 expressed in the indicated DC subsets in the mLNs 
and SI LP. Mean of three mice per group with SEM. *p=0.05, ***p<0.0009, ****p<0.0001; 
unpaired t-test.
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f) For pLNs and spleen, histograms show expression of YFP-Bcl-6 and YFP-Prdm1 within 
CD8α+ cDCs (purple) and CD11b+ cDCs (light blue). Representative of 2 technical 
replicates, n=3
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Fig. 7. Bcl-6-deficient mice lack splenic CD8α+and intestinal mSP DCs
a) Plots show live-gated lineage-negative (CD3, CD19, NK1.1) mLN cells. Relative 
frequency of cDC (CD11c+, B220neg) versus pDC (CD11c+, B220pos) in wild type, Bcl-6 
heterozygous, and Bcl-6-deficient mice. Representative of 4 biological replicates.
b) Plots show the relative abundance of CD11bsp, CD103+CD11b+ (mDP), and 
CD103+CD11b− (mSP) DC in mLNs, SI LP, and colon (gated on live, CD3, CD19, and 
NK1.1 negative, CD11c+, MHCIIhi cells). Representative of at least ten biological 
replicates.
c) Relative abundance of subsets defined by CD8α and CD11b in wild type versus Bcl-6 
knockout mice in pLN and spleen. Gated on live, CD3, CD19, and NK1.1 negative, CD11c 
positive, MHC class II high cells. Representative of at least ten biological replicates.
d) Subset composition of cDC derived from wild type versus Bcl-6 knockout donor BM in 
mixed bone marrow chimeras. Left column plots show wild type donor derived DC, right 
column plots show Bcl-6 knockout donor-derived DC. Representative of three replicates 
(n=3).
e) Wild type and Bcl-6 knockout BM-derived cDC populations in pLN and spleen.
f) SI LP DC subset contribution of wild type and Bcl-6 knockout derived donor cells to 
mDP and mSP DC. Cells were gated on live, lineage negative (CD3, CD19, NK1.1), 
CD11c+, and MHC class II+. Bars show the mean contribution in percent to the defined 
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subsets (mDP, mSP), wild type-derived cells in white, Bcl-6-derived cells in black. 
**p=0.002, unpaired t-test.
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Fig. 8. Blimp-1 deficiency specifically impairs intestinal mDP frequencies
a) Subset composition of gut-associated cDCs derived from Blimp-1fl/fl littermate controls 
(wt) versus Blimp-1fl/fl crossed to CD11c-cre mice (DCBlimp-1KO). Cells were gated on the 
live, lineage negative (CD3, B220, NK1.1), CD11chi, MHCIIhi population. Representative 
for two individual stainings of three pairs each and three individual stainings of three pairs 
each.
b) Subset composition of cDCs populations defined by CD8α and CD11b expression from 
the same mice as in c) in spleens and peripheral LNs.
c) Ratios of mDP to mSP DCs within CD11chiMHCIIhi, lineage negative (CD3, B220, 
NK1.1) live cells of mLNs and SI LP of DCBlimpKO (black bars) and littermate controls 
(grey bars); three mice each, mLN: **p = 0.005, SI LP: *p = 0.03
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